The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Insulin Therapy Is Associated With Platelet Dysfunction in Patients With Type 2 Diabetes Mellitus on Dual Oral Antiplatelet Treatment
Open accessAbstract
OBJECTIVES This study sought to assess the influence of type 2 diabetes mellitus (T2DM) and the impact of hypoglycemic treatment (insulin vs. noninsulin) on platelet function profiles in patients treated with dual oral antiplatelet therapy. BACKGROUND Insulin inhibits platelet aggregation by suppressing the P2Y12 pathway. However, T2DM patients have a loss of responsiveness to insulin that leads to upregulation of the P2Y12 pathway, increased platelet reactivity, and reduced responsiveness to antiplatelet agents. Patients with insulin-treated diabetes mellitus (ITDM) have a more advanced disease status and higher atherothrombotic risk compared with non-ITDM (NITDM). However, the impact of insulin therapy on platelet dysfunction in patients treated with P2Y12 antagonists is unknown. METHODS A total of 201 T2DM and 65 nondiabetic patients with coronary artery disease in a steady phase of aspirin and clopidogrel treatment were studied. Platelet aggregation was assessed using agonists specific (6 and 20 microM adenosine diphosphate [ADP]) and nonspecific (6 microg/ml collagen and 20 microM epinephrine) for the P2Y12 pathway. High shear-induced platelet reactivity was assessed by means of the PFA-100 system (Dade-Behring International, Miami, Florida). RESULTS The T2DM patients had platelet aggregation and shear-induced platelet function significantly increased compared with nondiabetic patients using all assays. Platelet aggregation was increased in ITDM (n = 68) compared with NITDM (n = 133) patients after P2Y12-specific stimuli. Insulin treatment was the strongest predictor of ADP-induced aggregation. Platelet function profiles were similar between ITDM and NITDM using assays nonspecific to the P2Y12 pathway. Platelet dysfunction was independent of glycemic control and inflammatory status. CONCLUSIONS The P2Y12-dependent and -independent pathways of platelet reactivity are altered in T2DM compared with nondiabetic patients, and ITDM have greater ADP-induced platelet aggregation compared with NITDM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1996) · The Lancet · doi:10.1016/s0140-6736(96)09457-3 · Cited by 6,503
(2001) · New England Journal of Medicine · doi:10.1056/nejmoa010746 · Cited by 6,470
Steinhubl, S. R., Berger, P. B., Mann III, J. T., Fry, E. T. A., DeLago, A., Wilmer, C., Topol, E. J., & for the CREDO Investigators (2002) · JAMA · doi:10.1001/jama.288.19.2411 · Cited by 3,078
Dennis, M. S. (1996) · The Lancet · Cited by 2,728
Gurbel, P. A., Bliden, K. P., Hiatt, B. L., & O’Connor, C. M. (2003) · Circulation · doi:10.1161/01.cir.0000072771.11429.83 · Cited by 1,544
Matetzky, S., Shenkman, B., Guetta, V., Shechter, M., Beinart, R., Goldenberg, I., Novikov, I., Pres, H., Savion, N., Varon, D., et al. (2004) · Circulation · doi:10.1161/01.cir.0000130846.46168.03 · Cited by 1,354
Platelet Dysfunction in Type 2 Diabetes
Vinik, A. I., Erbas, T., Park, T. S., Nolan, R., & Pittenger, G. L. (2001) · Diabetes Care · doi:10.2337/diacare.24.8.1476 · Cited by 671
Therapeutic roles of peroxisome proliferator-activated receptor agonists
Staels, B., & Fruchart, J.-C. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2460 · Cited by 646
Platelet Reactivity in Patients and Recurrent Events Post-Stenting
Gurbel, P. A., Bliden, K. P., Guyer, K., Cho, P. W., Zaman, K. A., Kreutz, R. P., Bassi, A. K., & Tantry, U. S. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.07.041 · Cited by 644
Thromboxane Biosynthesis and Platelet Function in Type II Diabetes Mellitus
Davì, G., Catalano, I., Averna, M., Notarbartolo, A., Strano, A., Ciabattoni, G., & Patrono, C. (1990) · New England Journal of Medicine · doi:10.1056/nejm199006213222503 · Cited by 597
Insulin and Atheroma: 20-Yr Perspective
Stout, R. W. (1990) · Diabetes Care · doi:10.2337/diacare.13.6.631 · Cited by 571
Angiolillo, D. J., Fernandez-Ortiz, A., Bernardo, E., Ramírez, C., Sabaté, M., Jimenez-Quevedo, P., Hernández, R., Moreno, R., Escaned, J., Alfonso, F., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2430 · Cited by 538
Self-citationPlatelet activation in type 2 diabetes mellitus
Ferroni, P., Basili, S., Falco, A., & Davì, G. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00836.x · Cited by 493
Chen, W.-H., Lee, P.-Y., Ng, W., Tse, H.-F., & Lau, C.-P. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.12.034 · Cited by 474
Abizaid, A., Kornowski, R., Mintz, G. S., Hong, M. K., Abizaid, A. S., Mehran, R., Pichard, A. D., Kent, K. M., Satler, L. F., Wu, H., et al. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00286-1 · Cited by 458
Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus
Bhatt, D. L., Marso, S. P., Hirsch, A. T., Ringleb, P. A., Hacke, W., & Topol, E. J. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02567-5 · Cited by 409
Abciximab reduces mortality in diabetics following percutaneous coronary intervention
Bhatt, D. L., Marso, S. P., Lincoff, A. M., Wolski, K. E., Ellis, S. G., & Topol, E. J. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00650-6 · Cited by 336
Platelet Function Testing in Cardiovascular Diseases
Michelson, A. D. (2004) · Circulation · doi:10.1161/01.cir.0000147228.29325.f9 · Cited by 317
Colwell, J. A., & Nesto, R. W. (2003) · Diabetes Care · doi:10.2337/diacare.26.7.2181 · Cited by 306
Large Platelets Circulate in an Activated State in Diabetes Mellitus
Tschoepe, D., Roesen, P., Esser, J., Schwippert, B., Nieuwenhuis, H., Kehrel, B., & Gries, F. (1991) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-1002650 · Cited by 266
Oxidant Stress and Aspirin-Insensitive Thromboxane Biosynthesis in Severe Unstable Angina
Cipollone, F., Ciabattoni, G., Patrignani, P., Pasquale, M., Di Gregorio, D., Bucciarelli, T., Davı̀, G., Cuccurullo, F., & Patrono, C. (2000) · Circulation · doi:10.1161/01.cir.102.9.1007 · Cited by 226
Platelet Inhibition by Insulin Is Absent in Type 2 Diabetes Mellitus
Ferreira, I. A., Mocking, A. I. M., Feijge, M. A. H., Gorter, G., van Haeften, T. W., Heemskerk, J. W. M., & Akkerman, J.-W. N. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000199519.37089.a0 · Cited by 213
Clopidogrel Resistance: A New Chapter in a Fast-Moving Story
Wiviott, S. D., & Antman, E. M. (2004) · Circulation · doi:10.1161/01.cir.0000134701.40946.30 · Cited by 199
Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention
Steinhubl, S. R., Berger, P. B., & Mann, J. T. (2003) · ACC Current Journal Review · doi:10.1016/s1062-1458(03)00075-8 · Cited by 191
Angiolillo, D. J., Fernández‐Ortíz, A., Bernardo, E., Barrera-Ramírez, C. F., Sabaté, M., Fernández, C., Hernández‐Antolín, R., Escaned, J., Alfonso, F., & Macaya, C. (2004) · PubMed · Cited by 187
Self-citationClinical application of the PFA-100®
Favaloro, E. J. (2002) · Current Opinion in Hematology · doi:10.1097/00062752-200209000-00004 · Cited by 178
Platelet hyperactivity and abnormal Ca2+homeostasis in diabetes mellitus
Li, Y., Woo, V., & Bose, R. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.280.4.h1480 · Cited by 177
Angiolillo, D. J., Fernandez-Ortiz, A., Bernardo, E., Ramírez, C., Sabaté, M., Jimenez-Quevedo, P., Hernández, R., Moreno, R., Escaned, J., Alfonso, F., et al. (2006) · Diabetes · doi:10.2337/diabetes.55.03.06.db05-1394 · Cited by 158
Self-citationMurphy, M. J., Metcalf, B. S., Voss, L. D., Jeffery, A., Kirkby, J., Mallam, K. M., & Wilkin, T. J. (2004) · PEDIATRICS · doi:10.1542/peds.113.1.82 · Cited by 152
Westerbacka, J., Yki‐Järvinen, H., Turpeinen, A., Rissanen, A., Vehkavaara, S., Syrjälä, M. T., & Lassila, R. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq0102.101546 · Cited by 145
IRS-1 Mediates Inhibition of Ca2+ Mobilization by Insulin via the Inhibitory G-protein Gi
Ferreira, I. A., Eybrechts, K. L., Mocking, A. I. M., Kroner, C., & Akkerman, J. N. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m305474200 · Cited by 117
Insulin resistance: sex matters
Mittendorfer, B. (2005) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000172574.64019.98 · Cited by 114
Decreased Platelet Membrane Fluidity Due to Glycation or Acetylation of Membrane Proteins
Winocour, P. D., Watała, C. W., Perry, D. W., & Kinlough-Rathbone, R. L. (1992) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1646320 · Cited by 110
The insulin resistance syndrome and coronary artery disease
Kendall, D. M., Sobel, B. E., Coulston, A. M., Peters, A. L., McLean, B. K., Peragallo‐Dittko, V., Buse, J. B., Fonseca, V. A., Hill, J. O., Nesto, R. W., et al. (2003) · Coronary Artery Disease · doi:10.1097/01.mca.0000076512.29238.2a · Cited by 61
Effect of clopidogrel on the expression of inflammatory markers in rabbit ischemic coronary artery
Molero, L., López-Farré, A. J., Mateos‐Cáceres, P. J., Fernández‐Sánchez, R., Maestro, M. L., Silva, J., Rodríguez, E., & Macaya, C. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706340 · Cited by 58
Self-citationInsulin treatment and cardiovascular disease; friend or foe? A point of view
Muis, M. J., Bots, M. L., Grobbee, D. E., & Stolk, R. P. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01416.x · Cited by 54
Insulin Enhances Platelet Activation In Vitro
Yngen, M., Li, N., Hjemdahl, P., et al. (2001) · Thrombosis Research · doi:10.1016/s0049-3848(01)00348-6 · Cited by 31
Optimization Of Insulin Therapy In Patients With Type 2 Diabetes
Bergenstal, R. M. (2000) · Endocrine Practice · doi:10.4158/ep.6.1.93 · Cited by 10
Alberti (1998) · doi:10.1002/(sici)1096-9136(199807)15:7<539::aid-dia668>3.0.co;2-s
Cited by
Variability in Individual Responsiveness to Clopidogrel
Angiolillo, D. J., Fernandez-Ortiz, A., Bernardo, E., Alfonso, F., Macaya, C., Bass, T. A., & Costa, M. A. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.11.044 · Cited by 959
Self-citationWiviott, S. D., Braunwald, E., Angiolillo, D. J., Meisel, S., Dalby, A. J., Verheugt, F. W. A., Goodman, S. G., Corbalan, R., Purdy, D. A., Murphy, S. A., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.791061 · Cited by 754
Self-citationAngiolillo, D. J., Shoemaker, S. B., Desai, B., Yuan, H., Charlton, R. K., Bernardo, E., Zenni, M. M., Guzman, L. A., Bass, T. A., & Costa, M. A. (2007) · Circulation · doi:10.1161/circulationaha.106.667741 · Cited by 447
Self-citationWallentin, L. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp296 · Cited by 409
Therapeutic strategies for thrombosis: new targets and approaches
Mackman, N., Bergmeier, W., Stouffer, G. A., & Weitz, J. I. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0061-0 · Cited by 388
Metadata
- Authors
- Angiolillo, D. J., Bernardo, E., Ramírez, C., Costa, M. A., Sabaté, M., Jimenez-Quevedo, P., Hernández, R., Moreno, R., Escaned, J., Alfonso, F., Bañuelos, C., Bass, T. A., Macaya, C., & Fernandez-Ortiz, A.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2006-07
- Volume
- 48
- Issue
- 2
- Pages
- 298-304
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2045872180
- Cited by
- 310
- References
- 39
- FWCI
- 15.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.